methyllycaconitine has been researched along with Encephalopathy, Toxic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Happ, DF; Tasker, RA | 1 |
| Camarasa, J; Chipana, C; Escubedo, E; Pérez-Sánchez, M; Pubill, D | 1 |
| Camarasa, J; Chipana, C; Escubedo, E; Pubill, D | 1 |
3 other study(ies) available for methyllycaconitine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Effects of α7 Nicotinic Receptor Activation on Cell Survival in Rat Organotypic Hippocampal Slice Cultures.
Topics: Aconitine; Animals; Cell Survival; Hippocampus; Neurotoxicity Syndromes; Nicotinic Agonists; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Synaptic Transmission; Temporal Lobe | 2018 |
Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antioxidants; Blotting, Western; Body Temperature; Body Weight; Calcium; Cell Membrane; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Immunohistochemistry; Isoquinolines; Male; Methamphetamine; Mice; Microglia; Motor Activity; Neostriatum; Neurotoxicity Syndromes; Nicotinic Antagonists; Radioligand Assay; Reactive Oxygen Species; Receptors, Nicotinic; Synaptic Vesicles; Synaptosomes; Tyrosine 3-Monooxygenase | 2005 |
Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: involvement of nicotinic receptors.
Topics: Aconitine; Analysis of Variance; Animals; Cocaine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Flow Cytometry; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Neurotoxicity Syndromes; Nicotinic Agonists; Nicotinic Antagonists; Radioligand Assay; Reactive Oxygen Species; Receptors, Nicotinic; Synaptosomes; Tritium | 2006 |